Item 1.01 Entry into a Material Definitive Agreement.

On September 19, 2022, Tricida, Inc. ("Tricida") and Patheon Austria GmbH & Co KG ("Patheon") entered into an amendment ("Amendment No. 4"), effective as of September 15, 2022, which amends certain terms of the Manufacturing and Commercial Supply Agreement, effective October 4, 2019 (as amended by amendment no. 1 dated March 30, 2021, amendment no. 2 dated August 26, 2021 and amendment no. 3 dated July 1, 2022, collectively the "Agreement"), between Tricida and Patheon.

Pursuant to Amendment No. 4, the parties have agreed to utilize the current, ongoing manufacturing campaign window to pursue validation and implementation of a second-generation manufacturing process. The amendment provides a payment structure that does not affect the total maximum amount payable to Patheon for the manufacturing campaign, which remains capped. There is no other material modification to the Agreement, including the recently executed amendment no. 3.

The foregoing description of terms of the Amendment No. 4 does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment No. 4. A copy of Amendment No. 4 will be filed with the Securities and Exchange Commission as an exhibit to Tricida's Quarterly Report on Form 10-Q for the third quarter ended September 30, 2022, or via an amendment to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits.

Exhibit Number              Description

                            Cover Page Interactive Data File (embedded within the Inline XBRL
104                         document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses